Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zamicastat extension study in PAH
NCT06009185Phase 2Completed
- Sponsor
- BIAL
- Start
- Jun 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of zamicastat in pulmonary arterial hypertension (PAH), sponsored by BIAL. Started Jun 2019; status: completed.
02
Drugs
zamicastat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT06009185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009185.